We first applied CIT in a case-control GWAS cohort and found statistical evidence of DNA methylation at HLA-DRB1 mediating the risk for MS from several SNPs located in the extended HLA locus. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.